Skip to main content

Table 1 Comparison of phenytoin and levetiracetam

From: Emergency treatment with levetiracetam or phenytoin in status epilepticus in children—the EcLiPSE study: study protocol for a randomised controlled trial

 

Phenytoin

Levetiracetam

Easy to administera

Rapid onset of actiona

Intermediate to long actiona

Broad spectruma

Minimal morbiditya

Useful as maintenance AEDa

IV solution compatibilitya

Rate of infusion

20 min (minimum)

5 min (minimum)

Effectiveness in CSE (seizure termination rate)

50–60%

75–100%

Evidence base

  

Cost

  

Interactions with other drugs

  

Adverse effects

  

Potentially fatal

Cardiac arrhythmia

Cardiac asystole

Stevens-Johnson syndrome

 

Non-fatal

Hypotension

Hepatotoxicity

Phlebitis

Severe extravasation injury (‘purple glove syndrome’)

Dizziness

Somnolence

Headache

Agitation

IV site irritation

  1. aCharacteristics of ideal intravenous AEDs as outlined by Wheless and Treiman [41]
  2. AED anti-epileptic drug, CSE convulsive status epilepticus, IV intravenous